Eidos Therapeutics, Inc. — Form D

Eidos Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-04-12. The offering totals $74.0M, of which $26.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2018-04-12
• Form: D
• Accession: 0001731831-18-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $74.0M
• Amount sold: $26.0M
• Remaining: $48.0M
• Investors: 13
• Date of first sale: 2018-03-29
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-309956

Issuer

• Name: Eidos Therapeutics, Inc.
• CIK: 0001731831
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2013
• Address: 101 MONTGOMERY STREET, SUITE 2550, SAN FRANCISCO, CA, 94104
• Phone: 415-887-1471

Officers, directors & promoters (8)

More

• CIK 1731831 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search